US3919205A
(en)
|
1972-07-17 |
1975-11-11 |
Squibb & Sons Inc |
Dithiocarbonylthioacetyl cephalosporin derivatives
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
FR2654725B1
(fr)
|
1989-11-23 |
1992-02-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
US5420297A
(en)
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
FR2676055B1
(fr)
|
1991-05-03 |
1993-09-03 |
Sanofi Elf |
Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
KR100214905B1
(ko)
|
1991-05-31 |
1999-08-02 |
디. 제이. 우드, 스피겔 알렌 제이 |
퀴누클리딘 유도체
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
CA2110513A1
(en)
|
1991-07-05 |
1993-01-21 |
Christopher J. Swain |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
EP0916346A3
(en)
|
1991-09-20 |
2000-12-06 |
Glaxo Group Limited |
NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
WO1993017032A1
(en)
|
1992-02-24 |
1993-09-02 |
The Trustees Of The University Of Pennsylvania |
Techniques and intermediates for preparing non-peptide peptidomimetics
|
FR2689889B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, et leur preparation.
|
TW241258B
(forum.php)
|
1992-04-15 |
1995-02-21 |
Takeda Pharm Industry Co Ltd |
|
US5719147A
(en)
|
1992-06-29 |
1998-02-17 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US6048859A
(en)
|
1992-06-29 |
2000-04-11 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
IL111002A
(en)
|
1993-09-22 |
1998-09-24 |
Glaxo Group Ltd |
Piperidine derivatives their preparation and pharmaceutical compositions containing them
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
|
TW385308B
(en)
|
1994-03-04 |
2000-03-21 |
Merck & Co Inc |
Prodrugs of morpholine tachykinin receptor antagonists
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
WO1996010562A1
(en)
|
1994-09-30 |
1996-04-11 |
Novartis Ag |
1-acyl-4-aliphatylaminopiperidine compounds
|
WO1996026183A1
(en)
|
1995-02-22 |
1996-08-29 |
Novartis Ag |
1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
CA2216701A1
(en)
|
1995-03-27 |
1996-10-03 |
Akira Okayama |
Piperidine derivatives
|
DE19519245C2
(de)
|
1995-04-14 |
2003-04-30 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9510600D0
(en)
|
1995-05-25 |
1995-07-19 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives
|
TW382017B
(en)
|
1995-12-27 |
2000-02-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
|
DE19608665A1
(de)
|
1996-03-06 |
1997-09-11 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
AU5239898A
(en)
|
1996-10-25 |
1998-05-15 |
Merck & Co., Inc. |
Phenyl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9700597D0
(en)
|
1997-01-14 |
1997-03-05 |
Sandoz Pharma Uk |
Organic compounds
|
JPH10259184A
(ja)
|
1997-03-18 |
1998-09-29 |
Takeda Chem Ind Ltd |
三環性複素環化合物の製造法
|
ZA985765B
(en)
|
1997-07-02 |
1999-08-04 |
Merck & Co Inc |
Polymorphic form of a tachykinin receptor antagonist.
|
PL338456A1
(en)
|
1997-08-06 |
2000-11-06 |
Lilly Co Eli |
2-acylaminopropanoamines as antagonists of the tachykinin receptor
|
TW426667B
(en)
|
1997-11-19 |
2001-03-21 |
Pfizer |
Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6291465B1
(en)
|
1999-03-09 |
2001-09-18 |
Hoffmann-La Roche Inc. |
Biphenyl derivatives
|
CO5150225A1
(es)
|
1999-03-19 |
2002-04-29 |
Merck Sharp & Dohme |
Derivados del tetrahidropirano y su uso como agentes terapeuticos
|
GB9907571D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Compounds
|
MXPA01011482A
(es)
|
1999-05-10 |
2003-07-21 |
Acordis Ind Fibers Gmbh |
Poliesteres y copoliesteres que formadores de hilo y metodod de fabricacion.
|
JP3229294B2
(ja)
|
1999-06-04 |
2001-11-19 |
キヤノン販売株式会社 |
被成膜面の改質方法及び半導体装置の製造方法
|
WO2001025233A1
(fr)
|
1999-10-07 |
2001-04-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Derives de piperidine
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
JP2003530388A
(ja)
|
2000-04-06 |
2003-10-14 |
アストラゼネカ・アクチエボラーグ |
医薬として使用するための新規なニューロキニン拮抗薬
|
EP1278719B1
(en)
|
2000-04-06 |
2005-11-02 |
AstraZeneca AB |
Naphthamide neurokinin antagonists for use as medicaments
|
GB0012240D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1327997A
(zh)
|
2000-06-12 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——Ras GTP酶激活蛋白9.57和编码这种多肽的多核苷酸
|
DE10036818A1
(de)
|
2000-07-28 |
2002-02-07 |
Solvay Pharm Gmbh |
Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
|
PE20020444A1
(es)
|
2000-09-22 |
2002-06-14 |
Merck & Co Inc |
Antagonistas de receptores de taquiquinina zwitterionica
|
SE0003476D0
(sv)
|
2000-09-28 |
2000-09-28 |
Astrazeneca Ab |
Compounds
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
US6642226B2
(en)
|
2001-02-06 |
2003-11-04 |
Hoffman-La Roche Inc. |
Substituted phenyl-piperidine methanone compounds
|
GB0108595D0
(en)
|
2001-04-05 |
2001-05-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB0114867D0
(en)
|
2001-06-18 |
2001-08-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0119797D0
(en)
|
2001-08-14 |
2001-10-03 |
Glaxo Group Ltd |
Chemical compounds
|
EP1295599A1
(en)
|
2001-09-21 |
2003-03-26 |
Boehringer Ingelheim International GmbH |
Method for the treatment of prevention of atopic dermatitis
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
BR0307156A
(pt)
|
2002-01-18 |
2004-12-07 |
Kyorin Seiyaku Kk |
Derivado de pirimidina bicìclica fundida, composto, antagonistas de receptores e agentes profiláticos e terapêuticos
|
WO2003066589A1
(en)
|
2002-02-08 |
2003-08-14 |
Glaxo Group Limited |
Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
|
GB0203020D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
GB0203022D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004002334A
(ja)
|
2002-03-25 |
2004-01-08 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
CA2483159C
(en)
|
2002-04-26 |
2010-08-10 |
Eli Lilly And Company |
Triazole derivatives as tachykinin receptor antagonists
|
JP2005535650A
(ja)
|
2002-07-03 |
2005-11-24 |
グラクソ グループ リミテッド |
タキキニンアンタゴニストおよびセロトニン再取り込み阻害剤としての置換4−フェニル−ピペリジン−アミド
|
GB0215392D0
(en)
|
2002-07-03 |
2002-08-14 |
Glaxo Group Ltd |
Chemical compounds
|
GB0217068D0
(en)
|
2002-07-23 |
2002-08-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0220953D0
(en)
|
2002-09-10 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
GB0310724D0
(en)
|
2003-05-09 |
2003-06-11 |
Glaxo Group Ltd |
Chemical compounds
|
JPWO2005019225A1
(ja)
|
2003-08-21 |
2007-11-01 |
杏林製薬株式会社 |
Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体
|
TWI341198B
(en)
|
2004-01-27 |
2011-05-01 |
Merck Sharp & Dohme |
Hydroisoindoline tachykinin receptor antagonists
|
US8108430B2
(en)
|
2004-04-30 |
2012-01-31 |
Microsoft Corporation |
Carousel control for metadata navigation and assignment
|
GB0412865D0
(en)
|
2004-06-09 |
2004-07-14 |
Glaxo Group Ltd |
Chemical compounds
|
WO2006060346A2
(en)
|
2004-12-03 |
2006-06-08 |
Merck & Co., Inc. |
8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
|
US20070293492A1
(en)
|
2004-12-03 |
2007-12-20 |
Devita Robert J |
Quinoline Tachykinin Receptor Antagonists
|
US7354922B2
(en)
|
2004-12-14 |
2008-04-08 |
Schering Corporation |
Bridged ring NK1 antagonists
|
JP2008523147A
(ja)
|
2004-12-14 |
2008-07-03 |
メルク エンド カムパニー インコーポレーテッド |
オクタヒドロピラノ[3,4−c]ピロールタキキニン受容体拮抗薬
|
US7939552B2
(en)
|
2005-03-31 |
2011-05-10 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Benzyloxypropylamine derivative
|
EP1965794A4
(en)
|
2005-12-22 |
2009-10-21 |
Merck & Co Inc |
OCTAHYDROPYRANO [3,4-c] pyrrole tachykinin receptor Antagonist
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
JP2007277231A
(ja)
|
2006-03-16 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
US20090286777A1
(en)
|
2006-05-15 |
2009-11-19 |
Jianming Bao |
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
|
EP2086641A2
(en)
|
2006-10-26 |
2009-08-12 |
Boehringer Ingelheim International GmbH |
Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
|
JP2008239618A
(ja)
|
2007-02-28 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
JP2010530874A
(ja)
|
2007-06-22 |
2010-09-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
6,5−ピロロピペリジンタキキニン受容体アンタゴニスト
|
US20110009629A1
(en)
*
|
2008-02-26 |
2011-01-13 |
Sandoz Ag |
Preparation of morpholine derivatives
|
US20100098772A1
(en)
|
2008-10-21 |
2010-04-22 |
Allergan, Inc. |
Drug delivery systems and methods for treating neovascularization
|
CA2778301C
(en)
|
2009-11-18 |
2016-06-14 |
Helsinn Healthcare Sa |
Compositions comprising palonosetron and netupitant for treating nausea and vomiting
|
US9197705B2
(en)
|
2013-04-12 |
2015-11-24 |
Samsung Electronics Co., Ltd. |
Method and apparatus for supporting driving using wireless communication network and system thereof
|
US11935002B2
(en)
|
2019-05-23 |
2024-03-19 |
Capital One Services, Llc |
Multi-lender platform that securely stores proprietary information for generating offers
|